Hyperlipoproteinemia, Type V (HLPP5)

Hyperlipoproteinemia, Type V(来自ICD-11)

别称:

Hyperlipoproteinemia Type V

Familial Type 5 Hyperlipoproteinemia

Hyperchylomicronemia, Late-Onset

Hyperchylomicronemia with Hyperprebetalipoproteinemia, Familial

Hyperlipemia, Combined Fat and Carbohydrate-Induced

Familial Hyperlipoproteinemia Type V

Hyperlipidemia, Familial Combined

Fredrickson Type V Lipaemia

Hyperlipidemia, Type V

Hyperlipoproteinemia 5

Mixed Hyperlipidemia

Hyperlipemia, Mixed

Hlpp5

加入收藏

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Hyperlipoproteinemia, Type V, also known as hyperlipoproteinemia type v, is related to xanthomatosis and acute pancreatitis, and has symptoms including hypertriglyceridemic waist An important gene associated with Hyperlipoproteinemia, Type V is APOA5 (Apolipoprotein A5), and among its related pathways/superpathways are Metabolism and Olfactory Signaling Pathway. The drugs Fenofibrate and Lovastatin have been mentioned in the context of this disorder. Affiliated tissues include heart, and related phenotypes are diabetes mellitus and decreased hdl cholesterol concentration

查看原文参与反馈